Roivant Sciences Ltd. (ROIV) Cash Flow Statement
Roivant Sciences Ltd. (ROIV) generated -$816.5M of operating cash flow over the twelve months to 2026-06-30, spent $4.6M on capital expenditure and had free cash flow of -$821.1M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ROIVRoivant Sciences Ltd.Follow ROIV — free
—
Price chart with a free account
- Market cap
- 26.4B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2022 Mar 22 | FY2023 Mar 23 | FY2024 Mar 24 | FY2025 Mar 25 | FY2026 Mar 26 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -0.68 | -0.84 | -0.77 | -0.84 | -0.75 | -0.82 | |
| Capital expenditure | 0.02 | 0.01 | 0.00 | 0.00 | 0.01 | -0.00 | |
| Free cash flow | -0.70 | -0.86 | -0.77 | -0.84 | -0.76 | -0.82 | |
| Share repurchases | — | 0.00 | 0.00 | 1.29 | — | — | |
| Stock-based compensation | 0.56 | 0.22 | 0.20 | 0.29 | 0.35 | — |
USD billions · SEC XBRL
Roivant Sciences Ltd. — questions
- What is Roivant Sciences Ltd.'s operating cash flow?
- -$816.5M over the twelve months to 2026-06-30.
- How much does Roivant Sciences Ltd. spend on capital expenditure?
- $4.6M over the twelve months to 2026-06-30.
- What is Roivant Sciences Ltd.'s free cash flow?
- -$821.1M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Roivant Sciences Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.